000 01535 a2200409 4500
005 20250516171433.0
264 0 _c20140825
008 201408s 0 0 eng d
022 _a2164-554X
024 7 _a10.4161/hv.26498
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMuthumani, Kar
245 0 0 _aOptimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab.
_h[electronic resource]
260 _bHuman vaccines & immunotherapeutics
_cOct 2013
300 _a2253-62 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xblood
650 0 4 _aBiological Therapy
_xmethods
650 0 4 _aFemale
650 0 4 _aHIV Antibodies
_xblood
650 0 4 _aHIV Infections
_xtherapy
650 0 4 _aHIV-1
_ximmunology
650 0 4 _aImmunoglobulin Fab Fragments
_xblood
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aPlasmids
_xadministration & dosage
650 0 4 _aRecombinant Proteins
_xblood
650 0 4 _aenv Gene Products, Human Immunodeficiency Virus
_ximmunology
700 1 _aFlingai, Seleeke
700 1 _aWise, Megan
700 1 _aTingey, Colleen
700 1 _aUgen, Kenneth E
700 1 _aWeiner, David B
773 0 _tHuman vaccines & immunotherapeutics
_gvol. 9
_gno. 10
_gp. 2253-62
856 4 0 _uhttps://doi.org/10.4161/hv.26498
_zAvailable from publisher's website
999 _c23097094
_d23097094